Key result
Bioinformatics analysis identified 524 differentially expressed genes and 10 hub genes, notably MAPK1 and UBE2D2, that are significantly associated with atrial fibrillation complicated by stroke.
Why the study?
Risk factors or predictors of stroke in AF patients have not been clarified, creating a need to find effective diagnostic and therapeutic targets.
What are the differentially expressed genes and potential diagnostic biomarkers for stroke in patients with atrial fibrillation?
Observational (n=108)
What are the differentially expressed genes and potential diagnostic biomarkers for stroke in patients with atrial fibrillation?
Bioinformatics analysis identified 10 hub genes, including MAPK1 and UBE2D2, which may serve as potential biomarkers or therapeutic targets for stroke in patients with atrial fibrillation.
Answers are grounded in this paper and cite their sources.
These associations should not change AF stroke management; they leave open biomarker or target potential pending prospective validation.
Atrial fibrillation (AF) increases the risk of ischemic stroke and systemic arterial embolism. However, the risk factors or predictors of stroke in AF patients have not been clarified. Therefore, it is necessary to find effective diagnostic and therapeutic targets. Two datasets were downloaded from the Gene Expression Omnibus (GEO) database. Differently expressed genes (DEGs) were identified between samples of atrial fibrillation without stroke and atrial fibrillation with stroke. Enrichment analysis of Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) by Gene Set Enrichment Analysis (GSEA), construction and analysis of protein-protein interaction (PPI) network and significant module, and the receiver operator characteristic (ROC) curve analysis were performed. A total of 524 DEGs were common to both datasets. Analysis of KEGG pathways indicated that the top canonical pathways associated with DEGs were ubiquitin-mediated proteolysis, endocytosis, spliceosome, and so on. Ten hub genes (SMURF2, CDC42, UBE3A, RBBP6, CDC5L, NEDD4L, UBE2D2, UBE2B, UBE2I, and MAPK1) were identified from the PPI network and were significantly associated with a diagnosis of atrial fibrillation and stroke (AFST). In summary, a total of 524 DEGs and 10 hub genes were identified between samples of atrial fibrillation without stroke and atrial fibrillation with stroke. These genes may serve as the target of early diagnosis or treatment of AF complicated by stroke.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2020) conducted an observational in Atrial fibrillation and stroke (n=108). Atrial fibrillation with stroke vs. Atrial fibrillation without stroke was evaluated on Differentially expressed genes (DEGs) and hub genes. Bioinformatics analysis identified 524 differentially expressed genes and 10 hub genes, notably MAPK1 and UBE2D2, that are significantly associated with atrial fibrillation complicated by stroke.
Synapse has enriched 10 related papers. Consider them for comparative context: